It will be good to compare the China numbers to what we are seeing out of Italy and the US in the next few weeks.
Italy is about the same size as Hebei. Currently China has roughly 11x the number of cases as Italy but Italy has a higher CFR. If this stays in track the Italy will have more deaths than China.. Yes, Italy has older demographic but does that make their deaths less important?
The real concern is the US who have handled this poorly and their health care system is just not equipmed to cope the the number of patients they will need to see and admit. They are currently only testing those that need to be hosptialised or have been on a petri dish of disease.
It will be an interesting couple of weeks. Buckle up.
- Forums
- ASX - By Stock
- CSL
- News: CSL Seqirus Receives FDA Approval For FLUAD® QUADRIVALENT
News: CSL Seqirus Receives FDA Approval For FLUAD® QUADRIVALENT, page-14
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$294.54 |
Change
-0.460(0.16%) |
Mkt cap ! $142.6B |
Open | High | Low | Value | Volume |
$295.01 | $296.50 | $293.51 | $60.14M | 203.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21 | $294.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$294.56 | 27 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 72 | 294.520 |
5 | 38 | 294.510 |
2 | 26 | 294.500 |
2 | 17 | 294.480 |
3 | 67 | 294.470 |
Price($) | Vol. | No. |
---|---|---|
294.560 | 44 | 5 |
294.570 | 19 | 4 |
294.590 | 11 | 2 |
294.600 | 25 | 3 |
294.610 | 28 | 2 |
Last trade - 15.20pm 10/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online